World Clinical Drug
|
2025, 46(11): 1194-1200
• Pharmacy administration •
Drug price negotiations in the United States Inflation Reduction Act:mechanism design logic, impact and global governance implications
Full
Xutao WANG1, 2, Miao WANG1, 2, Hong SU2, *
Affiliations
- 1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China
- 2.China National Pharmaceutical Industry Information Centre, Shanghai 200040, China
Published: 2025-11-10
doi: 10.13683/j.wph.2025.11.016
Outline
drug prices
/
price negotiations
/
Inflation Reduction Act
王旭涛, 王淼, 苏红.
美国《通货膨胀削减法案》中的药品价格谈判:机制设计、影响与启示.
世界临床药物,
2025
, 46
(11)
: 1194
-1200
.
DOI: 10.13683/j.wph.2025.11.016
Xutao WANG, Miao WANG, Hong SU.
Drug price negotiations in the United States Inflation Reduction Act:mechanism design logic, impact and global governance implications[J].
World Clinical Drug,
2025
, 46
(11)
: 1194
-1200
.
DOI: 10.13683/j.wph.2025.11.016
Year 2025 volume 46 Issue 11
45
10
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.11.016
- Receive Date:2025-04-27
- Online Date:2026-11-09
- Published:2025-11-10